Correlation Engine 2.0
Clear Search sequence regions


  • A2B (6)
  • Anta (5)
  • asthma (3)
  • basophil (1)
  • blood (3)
  • cell count (2)
  • cytokines (2)
  • eosinophil (1)
  • guinea pig (3)
  • IFN γ (1)
  • il 4 (2)
  • lung (2)
  • mrs1706 (3)
  • ovalbumin (2)
  • receptors (1)
  • serum (1)
  • zm241385 (2)
  • Sizes of these terms reflect their relevance to your search.

    Nowadays adenosine is specified as an important factor in the pathophysiology of asthma. For determining the effect of different A2 receptors, in this investigation the effect of single dose of selective adenosine A2A and A2B antagonists (ZM241385 and MRS1706) on different inflammatory parameters; tracheal responsiveness to methacholine and ovalbumin, total and differential cell count in bronchoalveolar lavage (BAL), blood levels of IL-4 and IFN-γ and lung pathology of guinea pig model of asthma were assessed. All mentioned parameters were evaluated in two sensitized groups of guinea pigs pretreated with A2A and A2B antagonists (S+Anta A2A, S+Anta A2B) compared with sensitized (S) and control (C) groups. The tracheal responsiveness to methacholine and OA, total cell and eosinophil and basophil count in BAL, blood IL-4 level and pathological changes in pre-treated group with MRS1706 (S+Anta A2B) was significantly lower than those of sensitized group (p<0.01 to p<0.05). In pretreated group with Anta A2A(S+Anta A2A), all the above changes were reversed. These results showed a preventive effect of A2B antagonist (MRS1706) on tracheal responsiveness to methacholine and OA, total and differential cell count in bronchoalveolar lavage, blood cytokines and pathological changes. Administration of ZM241385, selective A2A antagonist, deteriorated the induction effect of ovalbumin.

    Citation

    Laleh Pejman, Hasan Omrani, Zahra Mirzamohammadi, Amir Ali Shahbazfar, Majid Khalili, Rana Keyhanmanesh. The Effect of Adenosine A2A and A2B Antagonists on Tracheal Responsiveness, Serum Levels of Cytokines and Lung Inflammation in Guinea Pig Model of Asthma. Advanced pharmaceutical bulletin. 2014;4(2):131-8


    PMID: 24511476

    View Full Text